,7-dimethyl ether attenuates epileptic seizures in zebrafish and mouse models Epilepsy is one of the most common neurological diseases affecting more than 70 million people worldwide (Ngugi et al., 2010; Singh and Trevick, 2016) . It is characterized by the presence of spontaneous unprovoked recurrent seizures and involves risks of comorbidities, anxiety, depression and increased mortality. Moreover, patients suffer from social stigma and the stress of living with an unpredictable disease that can lead to loss of autonomy in daily life (Mosh e et al., 2015) . Even though over 25 anti-seizure drugs (ASDs) are on the market, seizures cannot be controlled in 30% of patients due to drug resistance (Dalic and Cook, 2016; Franco et al., 2016; Mosh e et al., 2015) . In fact, the probability of achieving seizure freedom did not lower since the 70s, despite the availability of new-generation ASDs (Franco et al., 2016) . In addition, existing ASDs have many adverse effects, ranging from gastrointestinal problems to hepatotoxicity and even cognitive impairment (L€ oscher et al., 2013; Mosh e et al., 2015) . Hence, there is an unmet need for the development of new and safe ASDs that can control seizures effectively and prevent seizure-induced neurological damage (L€ oscher, 2017; Łukawski et al., 2016) .
Significantly, inflammatory mediators such as cytokines and prostaglandins, released from brain cells and peripheral immune cells are involved in the origin of seizures, as well as in epileptogenesis (de Vries et al., 2016; Dey et al., 2016; L€ oscher et al., 2013; Vezzani et al., 2013) . Thus, in the search for more effective ASDs with novel mechanisms of action, anti-inflammatory agents have been proposed not only as potential ASDs but also as candidate anti-epileptogenic drugs (AEDs) that can prevent or favorably modify the development of epilepsy (Dey et al., 2016; Vezzani, 2015) .
Of interest, flavonoids and their glycosides have been shown to exert mild to potent activity in several seizure and epilepsy animal models (Sucher and Carles, 2015; Zhu et al., 2014) . Investigating the underlying mechanism of action, it was found that these structures modulate allosterically GABA A receptors by binding to the benzodiazepine receptor site (Hanrahan et al., 2011; Johnston, 2015) . However, flavonoids are also known to exert potent antiinflammatory effects in the brain by means of free-radicalscavenging activity (Diniz et al., 2015) , or by directly modulating key components of the neuroinflammatory cascade (Spencer et al., 2012) . Accordingly, this neuroprotective activity has been invoked to explain their anticonvulsant effects as well (Diniz et al., 2015; Golechha et al., 2014 Golechha et al., , 2011 Lin et al., 2015) .
Flavonoids are polyphenolic structures that are daily consumed due to their widespread distribution in almost all terrestrial plants with no adverse effects reported (J€ ager and Saaby, 2011; Tapas et al., 2008) . As such, dietary flavonoids and chemical derivatives thereof offer a possibly interesting source for ASD and AED chemical discovery work (J€ ager and Saaby, 2011; Marder and Paladini, 2002; Singh et al., 2014) . Although their pharmaceutical potential is often hampered by metabolic instability and low oral bioavailability, it has been argued that their drug-likeness can be improved via methylation of the free hydroxyl groups, dramatically enhancing the metabolic stability and membrane transport, facilitating absorption and highly increasing the bioavailability (Koirala, 2016; Koirala et al., 2016) . Of importance, this methylation also abrogates their chemical anti-oxidant capacity, but leaves the general protective activity of the compounds against oxidative stress intact (Deng et al., 2006) .
Since to the best of our knowledge no scientific data is available regarding the use of methylated flavonoids in the fight against epilepsy, we studied the anti-seizure activity of naringenin (NRG) and kaempferol (KFL), and of some of their common methylated derivatives, i.e., naringenin 7-O-methyl ether (NRG-M), naringenin 4 0 ,7-dimethyl ether (NRG-DM), and kaempferide (4 0 -O-methyl kaempferol) (KFD) (Fig. 1A) .
KFL belongs to the chemical subgroup of the flavonols that feature a double bond in the heterocyclic benzopyran moiety (C ring) resulting in planar A (fused aromatic ring) and C rings (Hanrahan et al., 2011) . Interestingly, KFL is a key active constituent of the extract of Crinum jagus L. that is used in traditional Cameroonian medicine as an anti-epileptic remedy. After isolation, the compound was found to improve convulsions-induced by pentylenetetrazole (PTZ) and to protect mice against PTZ-induced kindling development (Taiwe et al., 2016) .
NRG on the other hand belongs to the flavanones (Ferreira et al., 2014) , a subgroup with a puckered conformation of the C ring due to the lack of the double bond (Hanrahan et al., 2011) . NRG is found in citrus fruits and has strong anti-inflammatory and anti-oxidant activities (Alam et al., 2014; Miler et al., 2016; Patel et al., 2014; Renugadevi and Prabu, 2009) . It can pass the blood brain barrier, which enables the compound to exert neuroactive properties (Patel et al., 2014; Youdim et al., 2003) . Recently, NRG was shown to delay seizure onset, to ameliorate induced morphological brain alterations, and to reduce microglia-derived neuro-inflammation in a kainic acid-induced mouse seizure model (Park et al., 2016) . Of interest, NRG and KFL feature a highly similar hydroxylation pattern (Fig. 1A) , allowing for a better comparison between the biological activity of the two different flavonoid subgroups.
To evaluate the anti-seizure activity of the compounds, we used a zebrafish PTZ seizure model Baraban et al., 2005) , a standard assay in preliminary ASD discovery due to the high level of translation to rodents Buenafe et al., 2013; Orellana-Paucar et al., 2012) . Zebrafish are recognized as an important organism for modeling human diseases with respect to the 3R principle (Doke and Dhawale, 2015; Grone and Baraban, 2015) because it is a lower vertebrate model that is highly conserved with regard to the human reference genome (Howe et al., 2013) , physiology, and pharmacology (MacRae and Peterson, 2015) .
In this study, we show that the methylated NRG-M and NRG-DM are highly effective against PTZ-induced seizures in larval zebrafish, whereas NRG, KFL, and KFD possess only a limited activity. NRG-DM was further investigated in standard acute rodent seizure models, i.e., the mouse timed i.v. PTZ seizure model and the mouse 6-Hz psychomotor seizure model, and showed dose-dependent seizure reduction in both. Thus, highlighting the potential of methylated flavonoids as anti-seizure agents.
Material and methods

Experimental animals
All animal experiments carried out were approved by the Ethics Committee of the University of Leuven (approval numbers 101/ 2010, 061/2013, and 150/2015) and by the Belgian Federal Department of Public Health, Food Safety & Environment (approval number LA1210199) in accordance with the EU Directive 2010/63/ EU.
Zebrafish
Adult zebrafish (Danio rerio) stocks of AB strain (Zebrafish International Resource Center, Oregon, USA) were maintained at 28.0 C, on a 14/10 h light/dark cycle under standard aquaculture conditions. Fertilized eggs were collected via natural spawning and raised in embryo medium (1.5 mM HEPES, pH 7.2, 17.4 mM NaCl, 0.21 mM KCl, 0.12 mM MgSO 4 , 0.18 mM Ca(NO 3 ) 2 , and 0.6 mM methylene blue) at 28.0 C, under constant light.
Mice
Male C57Bl/6 mice (9 weeks old, Charles River Laboratories) and male NMRI mice (weight 18e20 g, Charles River Laboratories) were housed in polyacrylic cages under a 14/10-h light/dark cycle at 22 C. The animals were fed a pellet diet and water ad libitum and were allowed to acclimate for one week before experimental procedures were conducted.
Compound preparation and calculated LogP values
(±)-Naringenin, naringenin 7-O-methyl ether, kaempferol, and kaempferide (4 0 -O-methyl kaempferol) were purchased (analytical standard, Sigma-Aldrich). Naringenin 4 0 ,7-dimethyl ether was synthesized as previously described (Kim et al., 2007) . For experiments with zebrafish larvae, dry samples were dissolved in 100% dimethyl sulfoxide (DMSO, spectroscopy grade) as 100-fold concentrated stocks and diluted in embryo medium to a final concentration of 1% DMSO content. Control groups were treated with 1% DMSO (vehicle, VHC) in accordance with the final solvent concentration of tested compounds. For mice experiments, a mixture of polyethylene glycol M.W. 200 (PEG200) and 100% DMSO (spectroscopy grade, Acros Organics) (PEG200:DMSO 1:1) was used as solvent and VHC.
Calculated LogP values (cLogP) of the compounds were estimated with the interactive LogP calculator XLogP (version 3) (Cheng et al., 2007) based on the compound structure and were provided by PubChem as 2.4, 2.7, 3, 1.9, 2.2 for NRG, NRG-M, NRG-DM, KFL, and KFD, respectively.
Zebrafish pentylenetetrazole seizure model
Toxicity evaluation
Maximum tolerated concentration (MTC) was determined prior to further experiments and used as the highest test concentration. MTC was investigated by exposing 12 larvae of 7 days postfertilization (dpf) to a range of concentrations in a 100 mL volume during 18 h (28 C). After 1 h and 18 h of exposure touch response, morphology, posture, edema, signs of necrosis, swim bladder, and heartbeat were investigated. MTC was defined as the highest concentration at which no larvae showed signs of toxicity or locomotor impairment. In case no MTC was reached, the maximum soluble concentration was used.
Behavioral analysis
Experiments were performed as described before Orellana-Paucar et al., 2012) . In brief, a single 7-dpf larva was placed in each well of a 96-well plate and treated with VHC (1% DMSO) or compound in a 100 mL volume. Larvae were incubated in dark for 1 h at 28 C, whereafter 100 mL of either VHC (embryo medium) or 40 mM PTZ was added to each well. Next, within 5 min the larval behavior was video recorded in an automated tracking device (ZebraBox Viewpoint, France) during 30 min. Total locomotor activity per time period was measured in actinteg units (ZebraLab software Viewpoint, France).
Electrophysiology
Non-invasive local field potential (LFP) recordings (Zdebik et al., 2013) were measured from the optic tectum of 7-dpf zebrafish larvae pre-incubated with VHC only, PTZ only, compound and VHC, or compound and PTZ. Larvae were incubated for 1 h with VHC (1% DMSO) or the compound (MTC) in a 100 mL volume (28 C). After incubation, an equal volume of VHC (embryo medium) or 40 mM PTZ was added to the well for 15 min (28 C) prior to the recording. A larva was embedded in 2% low melting point agarose (Invitrogen) and the signal electrode [an electrode inside a blunt soda-glass pipet (Hilgenberg, Germany)] was positioned on the skin covering the optic tectum. Electrophysiological recordings (room temperature) were performed as described before (Sourbron et al., 2017; Zhang et al., 2017) . Manual analysis was done with Clampfit 10.2 software (Molecular Devices Corporation, USA). An electrical discharge was considered as epileptiform if it corresponded to a poly-spiking event comprising at least 3 spikes with a minimum amplitude of three times the baseline amplitude and a duration of at least 100 ms.
2.4. Determination of whole body compound concentrations in zebrafish 2.4.1. Equipment LC-MS analysis was performed using an Agilent 1 100 HPLC system, consisting of a G1311A quaternary pump and solvent module, a G1322A vacuum degasser, a G1313A autosampler (ALS), a G1315A diode-array (DAD) detector (operating at 280 nm) and a G1316A thermostatted column compartment (TCC, kept at a constant temperature of 25 C). The HPLC system was equipped with a Grace Prevail reversed-phase C18 3 mm column (length: 150 mm, ID: 2.1 mm) and coupled to an Agilent 6 110 single-quadrupole mass spectrometer with an electrospray ionization (ESI) source (capillary voltage: 3 500 V), operating in the positive mode. Samples (injection volume: 10 mL) were run in a mixture of methanol and water þ 0.1% formic acid (HPLC grade, Acros Organics) using a specific gradient program for each compound. For NRG (t R : 21.8 min), a linear gradient program was used, going from 40% to 100% methanol over a period of 40 min. For NRG-DM (t R : 31.2 min), a similar gradient was employed, starting initially at 50% methanol and reaching 100% over the same time period. All samples were run at a flow rate of 0.12 mL/min. Data were acquired and processed using Agilent LC/MSD ChemStation software rev. B.04.03-SP2 [105] . Further analysis was performed using Microsoft Excel 2016 and GraphPad Prism 5.
Sample preparation
Whole body compound concentrations were determined from extracts of 25 larvae of 7 dpf that were incubated for 1 h (dark incubation at 28 C) with 12.5 mM NRG-DM or 50 mM NRG (100 mL volume per larva in a 24-well plate), in accordance with the experimental conditions. Extraction protocol was based on literature (Kislyuk et al., 2017) . After incubation, larvae were washed to remove excess compound by flushing them with 15 mL of ultrapure water on a 74 mm polyester mesh (Costar). Next, larvae were anesthetized on an ice-cold petridish and transferred to 1.5 mL Eppendorf tubes with acid-washed glass beads (diameter: 710e1 180 mm, Sigma Aldrich) and 270 mL extraction medium (methanol:water 2:1, ultrapure water and HPLC grade methanol, Sigma Aldrich) within 3 min. The samples were homogenized by 30 min of ultrasonication (30 cycles of sonication and intermission of 30 s each, high energy input setting, Diagenode Bioruptor Plus, Seraing, Belgium) at 4 C. After centrifugation (14 000 g, 15 min), the supernatans was collected and stored on 4 C (short-term) or on À20 C (long-term) until further processing. Supernatants were filtered over a Millipore 0.45 mm syringe filter and the filter was rinsed three times with 2 mL methanol. The filtrate was lyophilized and the obtained solid residue was dissolved in 30 mL of the LC eluent. Two samples were pooled together and injected onto the LC-MS system to avoid the injection of air bubbles. batches of larvae by weighing 25 larvae (n ¼ 3 per batch) after removal of excess water on filter paper.
2.5. Mouse timed i.v. pentylenetetrazole seizure model 100 mL (weight-adjusted) of VHC (PEG200:DMSO 1:1) or treatment was i.p. injected in C57Bl/6 mice (10 weeks old, 23e30 g), 30 min prior seizure induction by continuous i.v. PTZ infusion through a catheter (7.5 mg/mL, 150 mL/min) connected to a syringe in an automatic pump. During PTZ infusion mice were observed in a transparent polyacrylic cage for the onset of the following behavioral events: ear-, tail-and myoclonic twitch, forelimb clonus, falling, tonic hind limb extension and death. PTZ doses needed to trigger the behavioral parameters were calculated based on the time latencies.
Mouse 6-Hz psychomotor seizure model
Experiments were performed as described before Orellana-Paucar et al., 2013) . In brief, 100 mL (weightadjusted) of VHC (PEG200:DMSO 1:1) or treatment was i.p. injected in NMRI mice (25e32 g), 30 or 120 (in case of phenytoin, as reported by Barton and colleagues (Barton et al., 2001) ) minutes prior seizure induction by corneal electrical stimulation (6 Hz, 0.2 ms pulse width, 3 s duration, 44 mA). VHC-treated mice typically displayed stun, twitching of the vibrissae, forelimb clonus, and Straub tail for at least 45 s. Mice displaying normal exploratory and locomotion behavior within a time period of 40 s were considered as protected against psychomotor seizures.
Results
3.1. Anti-seizure analysis of compounds using the zebrafish PTZ seizure model
We first explored the anti-seizure activity of the flavanone NRG, the flavonol KFL and their methylated derivatives, NRG-M, NRG-DM, and KFD, by analyzing their effects on the locomotor and brain activity of zebrafish larvae exposed to the GABA-antagonist PTZ. The flavonoids were tested at their maximum tolerated concentration (MTC) (i.e., 50 mM, 25 mM, and 12.5 mM in case of NRG, NRG-M, and NRG-DM, respectively) or their maximum soluble concentration (25 mM in case of KFL and KFD) and two two-fold dilutions thereof.
Upon exposure to PTZ the larvae exhibited a dramatically increased seizure-like behavior and locomotor activity (Fig. 1BeK) as documented before Baraban et al., 2005) . Furthermore, all compounds except for NRG induced a significant reduction in the PTZ-induced seizure behavior as analyzed during a 30-min tracking period, at least at the highest concentration used (Fig. 1BeF) . Overall, the most efficient compounds were NRG-M and NRG-DM that reduced PTZ-induced activity to ca 20e30% of the PTZ control activity, whereas KFL and KFD only had limited inhibitory activity. A more detailed analysis of the 30-min tracking period split into 5-min intervals confirmed the overall activity as observed for the active compounds (Fig. 1GeH, Fig. 1JeK ), but also revealed some effect by NRG, at least at the highest concentration tested (50 mM) (Fig. 1I) .
In absence of PTZ, a significant increase in larval locomotion in comparison to VHC-treated controls was observed for 25 mM NRG-M (p 0.01).
To confirm these results, we then incubated the zebrafish larvae with the compounds at their MTC and measured the epileptiform activity in the zebrafish larval optic tectum by non-invasive local field potential recordings. A significant reduction of larvae with PTZ-induced epileptiform activity was observed, in comparison to PTZ-treated controls, when the larvae were pre-exposed to NRG-DM (p 0.001), NRG-M (p 0.01), and KFL (p 0.05) ( Fig. 2A) . Moreover, NRG-DM and NRG-M also significantly lowered the number (p 0.001) and cumulative duration (p 0.001) of PTZinduced epileptiform events (Fig. 2BeC) . Consistent with the behavioral observations, NRG-M showed convulsive activity, significantly increasing the percentage of larvae that displayed epileptiform activity in comparison to VHC-treated controls (p 0.001). Likewise, NRG exposure increased the number of larvae with epileptiform activity proportionally (p 0.05) ( Fig. 2A) .
Determination of whole body concentrations of naringenin 4
0 ,7-dimethyl ether and naringenin in zebrafish
To investigate whether the methylation of naringenin affects the uptake in zebrafish, we determined the whole body concentrations of NRG-DM and NRG after exposure under the experimental conditions. Compound concentrations were measured from extracts of 25 larvae (n ¼ 3) that were incubated 1 h with either 12.5 mM NRG-DM or 50 mM NRG. Larvae exposed to NRG-DM had a mean whole body concentration (±SD) of 279.4 ng/mg (±81.3 ng/mg), equal to an uptake of 69.7 ng/larva (±20.3 ng/larva), while no quantifiable amounts of compound were detected for larvae exposed to NRG. Hence, the absorption of NRG-DM was observed to be more than 340-fold higher than that of NRG in the experimental conditions used.
Anti-seizure analysis of naringenin 4
0 ,7-dimethyl ether in the mouse timed i.v. pentylenetetrazole seizure model
We selected NRG-DM for further investigations in acute rodent seizure models. First, NRG-DM was tested in the mouse timed i.v. PTZ seizure model, a standard model for ASD discovery that is capable of identifying molecules with varied mechanisms of action (Mandhane et al., 2007 (Fig. 3 , Table 1 ).
0 ,7-dimethyl ether in the mouse 6-Hz psychomotor seizure model
To investigate whether NRG-DM has potential to control drugresistant seizures, of particular interest for refractory epilepsies, it was additionally tested in the mouse 6-Hz psychomotor seizure model (Barton et al., 2001) . This model involves electrical induction of drug-resistant seizures by a low frequency, long duration corneal stimulation (6 Hz, 0.2 ms rectangular pulse width, 3 s duration) at a current intensity of 44 mA (Barton et al., 2001; Walrave et al., 2015) . Treatment with 6.25 mg/kg NRG-DM (i.p. administered), 30 min before electrical stimulation, showed protection against psychomotor seizures in all mice (p 0.01). Protection was defined as the mouse displaying normal exploratory and locomotion behavior within a time period of 40 s. At 25, 12.5, and 2 mg/kg NRG-DM, protection was observed for 5 out of 6 mice (p 0.05). As expected, treatment with positive control, valproate (300 mg/kg, i.p. administered 30 min before electrical stimulation), led to complete protection (p 0.01), whereas treatment with negative control, phenytoin (10 mg/kg, i.p. administered 120 min before electrical stimulation), showed no significant protection (3 out of 6 mice protected) (Fig. 4A) . When comparing seizure duration in all conditions, a significant reduction is observed between the control group (mean duration 70 s) and mice treated with 6.25 mg/kg NRG-DM (p 0.05, mean duration 15 s), and with 300 mg/kg valproate (p 0.001, mean duration 0 s). A non-significant reduction in seizure duration was observed for 25, 12.5, and 2 mg/kg NRG-DM (mean durations 26, 31, and 38 s, respectively), as well as for 10 mg/kg phenytoin (mean duration 43 s) (Fig. 4B ).
Discussion
Using a PTZ-induced zebrafish seizure model we demonstrated in the present study that non-methylated flavonoids like NRG and KFL possess only limited anti-seizure activity, as shown by both behavioral testing and LFP measurements. Of interest, methylation of KFL (forming KFD or 4 0 -O-methyl kaempferol) increased only marginally the activity (as shown in the behavioral test), whereas methylation of NRGs (forming naringenin 7-O-methyl ether (NRG-M), and naringenin 4 0 ,7-dimethyl ether (NRG-DM)), had a clear impact on the outcome.
Significantly, it has been observed that methylation of flavonoids dramatically favors their metabolic stability and membrane transport, thereby facilitating absorption and positively affecting their bioavailability (Koirala, 2016; Koirala et al., 2016) . In the present study however we were not able to prove any metabolic advantage of the methylated vs the non-methylated compound as any clear metabolic turnover of NRG-DM was lacking (results not shown) and no quantifiable amounts but also no metabolites could be detected in case of NRG. Although zebrafish larvae are capable of extensive biotransformation after long incubations with compounds (96 h) (Brox et al., 2016) , it should be underscored that we used short incubation periods (1 h) throughout this study, thereby decreasing the probability of any metabolic turnover. This limited exposure could also account for the discrepancy between the relative lack of activity, as observed for NRG and KFL in this study, and the clear anti-seizure properties in acute and chronic epilepsy rodent models of the compounds, as described in earlier reports after oral and i.p. administration of relative large doses (Park et al., 2016; Taiwe et al., 2016) .
Conversely, we observed that the whole-body uptake of NRG-DM by zebrafish larvae was at least 340-fold higher than that of NRG, and although the actual brain concentrations of the individual compounds are not known, it is anticipated that the difference in activity between the compounds relates to their differential uptake. The dramatically enhanced absorption of dimethylated NRG in comparison to its nonmethylated counterpart is therefore in agreement with earlier observations that methylation of flavonoids facilitates absorption (Koirala, 2016; Koirala et al., 2016) . However, the discrepancy between the recovery of the two compounds is nonetheless surprising, especially in view of the fact that NRG-DM and NRG have similar physicochemical properties (M r : 300 and 270, cLogP: 3.0 and 2.4, respectively), and that small molecules with LogP > 1 are expected to exhibit good bioavailability in zebrafish larvae (Milan et al., 2003) . Although any mechanistic background is lacking to explain these results, it is known that some compounds including polyphenolics can aspecifically interfere with many cellular proteins (Baell and Walters, 2014) , in case of larval skin possibly resulting in poor absorption characteristics.
In spite of the fact that methylation of flavonoids could raise the biological activity by increasing compound bioavailability , as seen for NRG-DM in this study, it could also confer new pharmacological activity to the original structure. Therefore, the low activity as observed for the non-methylated NRG and KFL, but also in case of the monomethylated KFD, might also point to an inappropriate pharmacological profile of the compound that is unable to phenotypically rescue the PTZ-induced pathological state. The clear convulsive properties of NRG-M are also in accordance with this assumption as likely this adverse effect is due to an unknown off-target activity not activated by the other compounds, or to differences in affinities for a common target. Often, when commonly used ASDs are overdosed or inadequately chosen, seizure aggravation and induction have been reported, thus revealing a sensitive balance between anti-and pro-seizure activities (Gayatri and Livingston, 2006; Sazgar and Bourgeois, 2005) .
Probably, also the site of methylation (4 0 versus 7) plays an important role in the pharmacological spectrum, as KFD (4 0 -Omethyl kaempferol) did not have a positive impact on the PTZinduced abnormal brain activity (as measured during LFP recordings), whereas NRG-M (naringenin 7-O-methyl ether) had a clear effect on this read-out. But obviously, also the difference in chemistry between the flavanone NRG and the flavonol KFL might have accounted for this discrepancy.
From all compounds studied in the zebrafish model, NRG-DM was most effective against PTZ-induced seizures and epileptiform discharges and did not induce convulsant effects. Hence, NRG-DM is considered a promising anti-seizure hit and was further investigated in standard acute mouse seizure models that are commonly used for ASD discovery. The mouse timed i.v. PTZ seizure model (Mandhane et al., 2007; Nutt et al., 1986 ) is a rodent correlate of the zebrafish PTZ model that can identify molecules with varied mechanism of action (Mandhane et al., 2007) . In this model generalized myoclonic, clonic, and tonic seizures are induced by continuous PTZ infusion through the tail vein (Bialer and White, 2010; L€ oscher, 2009; Mandhane et al., 2007) . NRG-DM treatment enhanced the mean PTZ dose needed to trigger multiple seizure parameters, including death, for which a dose-dependent effect was seen. These results confirm NRG-DM's anti-seizure activity in a mammalian model, thus providing an additional example of the translation of results from zebrafish to rodents, which has been previously reported Buenafe et al., 2013; Leclercq et al., 2015; Orellana-Paucar et al., 2013) . Moreover, these results show that NRG-DM is active against generalized seizures. Finally, besides anticonvulsant assessment this mouse model also allows the determination of (pro)convulsant drug activity, if any, which is seen as a significant reduction in the seizure threshold of one of the behavioral parameters. In line with the results obtained in the zebrafish PTZ seizure model, NRG-DM did not show convulsant properties in the mouse timed i.v. PTZ seizure model.
The activity of NRG-DM was also investigated in the mouse 6-Hz psychomotor seizure model in which drug-resistant focal seizures are electrically induced through the cornea with a current intensity of 44 mA (Barton et al., 2001 ). The 6-Hz (44 mA) model is considered a gold standard in current ASD discovery efforts, such as the U.S. Epilepsy Therapy Screening Program, as it can detect compounds with novel anti-seizure mechanisms and potential against drug-resistant focal seizures as exemplified by levetiracetam (Barton et al., 2001; Wilcox et al., 2013) . In this study, NRG-DM treatment ameliorated the induced psychomotor seizures resulting in protection of mice at all doses tested. Thus, NRG-DM is shown to have a broad utility against both generalized seizures and drugresistant focal seizures. Based on its prominent anti-seizure activity in zebrafish and mouse seizure models, we propose NRG-DM as a lead compound that is worth further investigations in the treatment of generalized seizures and, of particular interest, for the treatment of drug-resistant focal seizures.
The molecular mechanisms by which NRG-DM but also NRG-M exert their pronounced anti-seizure activity and to what extent they are substantially different from the parent compound NRG is presently unknown. NRG has only a mild affinity for the GABA Areceptor benzodiazepine site (J€ ager et al., 2007) , and thus its antiseizure activity is unlikely due to this target modulation solely. However, the compound also possesses strong anti-oxidant and anti-inflammatory activities (Alam et al., 2014; Park et al., 2016; Raza et al., 2013) , which are known to be relevant for its antiseizure and neuroprotective activity (de Vries et al., 2016; Dey et al., 2016; Shin et al., 2011) . For instance, in a mouse kainic acid-induced seizure model, NRG attenuated interleukin 1b (IL-1b) production (Park et al., 2016) , an important pro-inflammatory mediator in epileptogenic foci (Dey et al., 2016) , and also a targeted inhibition of the Toll-like receptor 4 (TLR4)/nuclear factor kB (NF-kB) signaling pathway was suggested to be an important mechanism of action (Dou et al., 2013) . Although methylation abolishes the chemical anti-oxidant properties of flavonoids (i.e., scavenging reactive oxygen species) (Deng et al., 2006) , the activity that triggers cellular anti-oxidant mechanisms remains intact. For instance, it has been reported that also NRG-M downregulates TNFa, IL-6, and IL-1b in lipopolysaccharide-stimulated macrophages in vitro by suppressing the activation of the ERK1/2, JNK, and NF-kB signaling pathways (Soromou et al., 2012) . So, methylation (and possibly also double methylation as in the case of NRG-DM) does not destroy the anti-inflammatory activity of NRG, although the potency and spectrum of inhibitory actions exhibited by the compounds might vary. Moreover, methylation can also confer a distinctive pharmacological characteristic to flavonoids. This is exemplified by hispidulin, a methylated apigenin, that exhibits a different profile of activity at GABA A receptors as compared to the parent compound (Johnston, 2015) , and by NRG-M and NRG-DM that inhibit voltage-gated potassium channels K v 1.3 in T-lymphocytes, whereas NRG did not (Teisseyre et al., 2009) . Although further research is needed to elucidate the molecular anti-seizure targets of NRG-DM and NRG-M, these data as well as our results indicate that methylation of flavonoids yields a distinct pharmacological spectrum that can be particularly relevant for anti-seizure drug discovery.
Conclusions
In this study, the potential of methylated flavonoids as a source for anti-seizure drug discovery was investigated using NRG, KFL, and three common methylated derivatives as a case study. We demonstrate that the methylated flavanones NRG-DM and NRG-M are highly effective against PTZ-induced seizures in larval zebrafish, whereas the flavanone NRG and the flavonols KFL and KFD possess only a limited activity. Even though a differential compound uptake might explain the results, it does not exclude the possibility that methylation of flavonoids can alter their pharmacological target(s). In addition, the promising anti-seizure hit NRG-DM is shown to be active in two standard acute mouse seizure models, i.e., the timed i.v. PTZ seizure model and the 6-Hz psychomotor seizure model. Based on these results, we propose NRG-DM as a lead compound worth investigating further for the treatment of generalized myoclonic, clonic, and tonic seizures, and, of particular interest, for the treatment of drug-resistant focal seizures. Our data therefore highlights the potential of methylated flavonoids in the search for new and improved ASDs.
